Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose TMZ/Thiotepa/Carboplatin + ASCR and Isotretinoin for Brain Tumors
NCT00528437Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Oct 2005
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of temozolomide, isotretinoin in Malignant Brain Tumor, sponsored by NYU Langone Health. Started Oct 2005; status: completed.
02
Drugs
temozolomideisotretinoin
03
Conditions
Malignant Brain Tumor
Beyond the preview
Go deeper on NCT00528437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00528437.